Skip to main content

ORIGINAL RESEARCH article

Front. Endocrinol.
Sec. Clinical Diabetes
Volume 16 - 2025 | doi: 10.3389/fendo.2025.1465242
This article is part of the Research Topic NAFLD treatment in diabetes: from current dietary interventions to novel treatment View all 5 articles

The U-Shaped Association of Fasting Plasma Glucose to HbA1c Ratio with Mortality in Diabetic and Prediabetic Populations: The Mediating Role of Systemic Immune-Inflammation Index

Provisionally accepted
Ming Yang Ming Yang Qing Shangguan Qing Shangguan Guobo Xie Guobo Xie Guotai Sheng Guotai Sheng Jingqi Yang Jingqi Yang *
  • Jiangxi Provincial People's Hospital, Nanchang, Jiangxi Province, China

The final, formatted version of the article will be published soon.

    Backgounds: This study aimed to assess the association between fasting plasma glucose to glycated hemoglobin (FPG/HbA1c) ratio and mortality and to explore the mediating role of immunity and inflammation in diabetic and prediabetic populations.Methods: Our analysis included 10,267 participants with prediabetes or diabetes from the NHANES (1999NHANES ( -2018)). The association between the FPG/HbA1c ratio and all-cause and cardiovascular(CVD) mortality was assessed using multivariate Cox proportional hazards models, restricted cubic splines(RCS), two-piecewise Cox proportional hazards models and sensitivity analysis. Mediation analysis was conducted to evaluate the systemic immune-inflammation index (SII) as a potential mediator.Results: Over a median follow-up of 103 months, there were 535 CVD deaths and 1918 all-cause deaths. After multivariate adjustment, a U-shaped relationship was observed between the FPG/HbA1c ratio and both CVD and all-cause mortality, with threshold points at 1.080 and 1.013, respectively. Below the thresholds, the FPG/HbA1c ratio was negatively associated with CVD mortality (HR:0.200, 95% CI: 0.072, 0.559) and all-cause mortality(HR: 0.242, 95% CI: 0.118, 0.494). Above the thresholds, the ratio was positively associated with CVD mortality (HR=3.691, 95% CI: 2.011, 6.772) and all-cause mortality (HR=3.025, 95% CI: 2.279, 4.016). Mediation analysis revealed that SII mediated 19.02% of the association with CVD mortality and 8.86% with all-cause mortality (P < 0.05).In the prospective cohort, the FPG/HbA1c ratio demonstrated a U-shaped association with mortality in diabetic and prediabetic adults, with SII playing a significant mediating role. These findings suggest that interventions targeting immunity and inflammation may improve clinical outcomes in these populations.

    Keywords: Fasting plasma glucose to glycated hemoglobin ratio, Mortality, Immunity, Inflammation, diabetes

    Received: 16 Jul 2024; Accepted: 08 Jan 2025.

    Copyright: © 2025 Yang, Shangguan, Xie, Sheng and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Jingqi Yang, Jiangxi Provincial People's Hospital, Nanchang, 330006, Jiangxi Province, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.